Web Stats Provided By Google Analytics

The Raw Stem Cell News Feed

The Stem Cell Research Newswire: Comprehensive Real-Time News Feed for Stem Cell Research

Wednesday, May 14, 2014

Astellas Reports Additional Data On Positive Isavuconazole Phase 3 SECURE Study At ECCMID

Baseline characteristics of the severely ill patient population enrolled in this trial were balanced between treatment groups and were reflective of patients at risk for invasive fungal disease .

http://ift.tt/QJHJGr

No comments:

Post a Comment

Popular Stem Cell Roundup Posts